Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P21+2+4+0+0
S48+1+1+0+0

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2017-04-24
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$26.92-38,6363,548,041-1%-$1,040,198
D
2017-04-24
IONSIonis Pharmaceuticals IncO'Neil Patrick R.SVP, Legal, GCS - Sale+OE$45.00-50010,449-5%-$22,500
2017-04-25
MBRXMoleculin Biotech, Inc.Foster Jonathan P.Exec. VP, CFOP - Purchase$0.86+10,00010,000New+$8,649
D
2017-04-24
SUPNSupernus Pharmaceuticals IncPatrick Gregory SVP, CFOS - Sale+OE$32.37-54,000221-100%-$1,747,872
2017-04-24
KERXKeryx Biopharmaceuticals IncNeylan John F.Chief Medical OfficerS - Sale$5.73-1,209130,685-1%-$6,928
2017-04-26
RXIIRxi Pharmaceuticals CorpCauwenbergh GeertPres, CEOP - Purchase$0.65+10,000117,533+9%+$6,480
2017-04-21
NBRVNabriva Therapeutics AGHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$11.04-2,6222,609,9010%-$28,937
2016-09-16
ARLZAralez Pharmaceuticals Inc.Aryeh JasonDirP - Purchase$5.86+295,929350,716+540%+$1,732,664
D
2017-04-24
HRTXHeron Therapeutics, Inc. /de/Manhard KimberlyEVP, Drug DevelopmentS - Sale+OE$15.33-21,5420-100%-$330,2630
DM
2017-04-20
SCLNSciclone Pharmaceuticals IncBlobel FriedhelmPres, CEOS - Sale+OE$9.56-40,00092,526-30%-$382,4700
M
2017-03-23
CBISCannabis Science, Inc.Kane Robert JamesCOOS - Sale$0.08-500,0008,236,485-6%-$41,171
2017-04-24
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale$32.59-11,80645,500-21%-$384,762+2
2017-04-24
AGIOAgios Pharmaceuticals IncCelgene European Investment Co LLC10%P - Purchase$49.50+624,5755,867,279+12%+$30,916,463+6
2017-04-19
CNABUnited Cannabis CorpBlackmon EarnestPres, CEO, 10%S - Sale$1.29-40,00021,488,2130%-$51,644
2017-04-21
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.07+3,00020,305,9490%+$202
2017-04-21
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+33,00020,302,9490%+$2,049
M
2017-04-19
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.07+32,00020,269,9490%+$2,116
A
2017-04-18
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+20,10020,237,9490%+$1,303
2017-04-21
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.48+19,000184,257,6560%+$142,197+1
2017-04-18
ARDXArdelyx, Inc.Rosenbaum David P.Chief Development OfficerS - Sale$11.98-2,051118,998-2%-$24,5770
D
2017-04-20
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$121.14-1,260654,0030%-$152,633+1
2017-04-19
TOCATocagen IncDas AshaSVP, Chief Medical OfficerP - Purchase$10.00+2,5002,500New+$25,000+1
2017-04-19
TOCATocagen IncFoletta Mark GEVP, CFOP - Purchase$10.00+5,0005,000New+$50,000+1
D
2017-04-19
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$43.25-5,500766,467-1%-$237,875+3
2017-04-19
TOCATocagen IncGruber Harry EPres, Research, DevelP - Purchase$10.00+25,000417,753+6%+$250,000+1
D
2017-04-19
TOCATocagen IncSchimmel PaulDirP - Purchase$10.00+10,00044,827+29%+$100,000+1
2017-04-19
TOCATocagen IncHasnain FaheemDirP - Purchase$10.00+100,000202,857+97%+$1,000,000+1
E
2017-04-18
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.11+20,00060,692,5470%+$2,298
M
2017-04-18
NBRVNabriva Therapeutics AGHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$11.11-23,9322,612,523-1%-$265,889+2
M
2017-04-19
CNABUnited Cannabis CorpRuby ChadCOOS - Sale$1.23-24,945733,722-3%-$30,621
2017-04-19
VSARVersartis, Inc.Westberg PaulSVP, Chief Business OfficerS - Sale$19.85-1,31668,228-2%-$26,1230
D
2017-04-19
MGNXMacrogenics IncWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-15,00030,000-33%-$300,000-1
M
2017-04-19
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.24+9,0003,733,2570%+$2,170
2017-04-19
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.49+15,000184,238,6560%+$112,291+1
M
2017-04-17
EEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.11+12,00020,217,8490%+$1,268+1+4
2017-04-17
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+29,00020,205,8490%+$1,549
M
2017-04-17
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$7.46-68,4853,988,879-2%-$510,945+1+3
D
2017-04-17
NKTRNektar TherapeuticsChess RobertDirS - Sale+OE$18.72-5,000271,623-2%-$93,600+3+4
M
2017-03-29
QBIOQ Biomed Inc.Lindsay Alan P10%S - Sale$6.11-11,9001,262,245-1%-$72,712
2017-04-17
FGENFibrogen IncKurkijarvi KaleviDirS - Sale$25.25-2,00038,000-5%-$50,500+2+9
2017-04-17
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickSVP, US CommercialS - Sale$152.56-20022,562-1%-$30,512+2+2
M
2017-04-17
AGIOAgios Pharmaceuticals IncCantley Lewis Clayton Jr.DirS - Sale$54.37-5,090233,470-2%-$276,753-1+3
2017-04-19
ORMPOramed Pharmaceuticals Inc.Li XiaopengDirP - Purchase$6.33+52,814116,714+83%+$334,313+2+21
2017-04-19
ORMPOramed Pharmaceuticals Inc.Kidron MiriamChief Scientific OfficerS - Sale$6.33-52,81489,636-37%-$334,313+2+21
2017-04-17
AXONAxovant Sciences Ltd.Vernon W AnthonyDirP - Purchase$18.54+53,93753,937New+$999,992+1+6
2017-04-17
AXONAxovant Sciences Ltd.Falberg Kathryn EDirP - Purchase$18.54+53,93753,937New+$999,992+1+6
D
2017-04-17
PRTAProthena Corp PlcWalker Karin LSee RemarksS - Sale+OE$52.25-5,0000-100%-$261,262+3+5
2017-04-17
AXONAxovant Sciences Ltd.Hung DavidPrincipal Exec OfficerP - Purchase$18.54+539,375539,375New+$10,000,013+1+6
2017-04-18
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.31-11,60013,673,8040%-$15,196
2017-04-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.26+27,800184,223,6560%+$201,790+6+10
D
2017-04-17
DERMDermira, Inc.Griffith Christopher M.SVP Head Corp. Dev., StrategyS - Sale+OE$33.97-1,30345,113-3%-$44,2670-2
2017-04-17
FLXNFlexion Therapeutics IncBodick NeilChief Medical OfficerS - Sale$28.23-5,000434,620-1%-$141,132-2-5
D
2017-04-17
PETXAratana Therapeutics, Inc.St Peter StevenPres, CEOS - Sale+OE$5.54-50,000716,356-7%-$277,150+2+8
D
2017-04-17
SELBSelecta Biosciences IncJohnston Lloyd P.COO, SVP, R, DS - Sale+OE$13.95-13,2051,606-89%-$184,2100-6
D
2017-04-17
ALKSAlkermes Plc.Ehrich ElliotEVP, R, D, CMO, Alkermes, Inc.S - Sale+OE$56.60-10,00055,071-15%-$565,986+1+1
2017-04-17
KERXKeryx Biopharmaceuticals IncAdams BrianGC, SecretaryS - Sale$5.75-1,090139,577-1%-$6,268-1+1
M
2017-04-13
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+11,00020,176,8490%+$612
2017-04-17
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.48+13,600184,195,8560%+$101,676-5+2
2017-04-17
CNABUnited Cannabis CorpVerzura TonyVP, 10%S - Sale$1.34-48,40013,644,5610%-$64,672
2017-04-17
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale$56.02-3,000206,583-1%-$168,060-2-5
D
2017-04-17
MKubota Pharmaceutical Holdings Co LtdScheibler LukasEVP of Research, DevelopmentS - Sale+OE$6.48-1,3206,943-16%-$8,5540+2
2017-04-14
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.24+2,0003,724,2570%+$480
M
2017-04-12
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.05+32,00020,165,8490%+$1,724
A
2017-04-11
PTLAPortola Pharmaceuticals IncLis WilliamCEOS - Sale$36.06-6,7504,730-59%-$243,405-10
DM
2017-04-12
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$24.79-38,6363,548,877-1%-$957,670-1+2
2017-04-12
MBVXMabvax Therapeutics Holdings, Inc.Maffuid Paul WEVPS - Sale$2.00-1,36921,226-6%-$2,738+4+1
2017-04-12
MBVXMabvax Therapeutics Holdings, Inc.Hanson Gregory PCFO, SECRS - Sale$2.00-3,88529,206-12%-$7,770+4+1
2017-04-12
MBVXMabvax Therapeutics Holdings, Inc.Hansen John DavidPres, CEOS - Sale$2.00-10,21661,473-14%-$20,433+4+1
D
2017-04-13
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$122.12-1,258653,0870%-$153,62500
2017-04-12
CTMXCytomx Therapeutics, Inc.Starr Kevin P10%S - Sale$16.36-28,3575,201,767-1%-$463,793-2+2
2017-04-12
OMEROmeros CorpCable Thomas J.DirS - Sale$16.49-3,00040,067-7%-$49,474+4+4
M
2017-03-29
QBIOQ Biomed Inc.Rosenstadt William SGC, 10%S - Sale$6.52-9,400975,549-1%-$61,276
2017-04-13
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.58+30,800184,182,2560%+$233,400-2-2
M
2017-04-11
NBRVNabriva Therapeutics AGHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$11.24-32,8312,636,455-1%-$368,919+3-3
M
2017-04-11
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.06+13,00020,133,8490%+$836
M
2017-04-10
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.08+29,00020,120,8490%+$2,296
2017-04-11
JAZZJazz Pharmaceuticals PlcCozadd Bruce CCOB, CEOS - Sale$152.12-1,000308,4910%-$152,1200+1
2017-04-12
IONSIonis Pharmaceuticals IncO'Neil Patrick R.SVP, Legal, GCS - Sale$40.07-1,00010,449-9%-$40,0700+2
DM
2017-04-12
IONSIonis Pharmaceuticals IncCrooke Stanley TCOB, CEOS - Sale+OE$40.69-22,000766,467-3%-$895,0700+2
D
2017-04-10
OHRPOhr Pharmaceutical IncSlakter Jason ScottCEOP - Purchase$0.70+142,8582,263,622+7%+$100,001+60
D
2017-04-10
OHRPOhr Pharmaceutical IncBackenroth SamuelCFOP - Purchase$0.70+71,429212,596+51%+$50,000+60
D
2017-04-10
OHRPOhr Pharmaceutical IncHirschman OrinDirP - Purchase$0.70+142,8581,787,805+9%+$100,001+60
2017-04-11
TGTXTg Therapeutics, Inc.Kennedy William JamesDirS - Sale$10.27-8,54870,401-11%-$87,788-1+3
D
2017-04-10
RNNRexahn Pharmaceuticals, Inc.Ahn Chang HoDirS - Sale+OE$0.70-250,0006,510,000-4%-$175,375-26-32
2017-04-11
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.49+18,000184,151,4560%+$134,909+10
2017-04-10
ICPTIntercept Pharmaceuticals IncShapiro DavidCMO, EVP - DevelopmentS - Sale$108.51-55845,465-1%-$60,549-3-2
D
2017-04-10
JAZZJazz Pharmaceuticals PlcWilson Karen JSVP, Finance, PAOS - Sale+OE$152.24-11,45822,408-34%-$1,744,366-1-1
2017-04-11
CNABUnited Cannabis CorpRuby ChadCOOS - Sale$1.39-30,000758,667-4%-$41,755
M
2017-04-07
MBVXMabvax Therapeutics Holdings, Inc.Maffuid Paul WEVPS - Sale$2.00-1,05022,595-4%-$2,102+9+5
M
2017-04-07
MBVXMabvax Therapeutics Holdings, Inc.Hanson Gregory PCFO, SECRS - Sale$2.00-1,05033,091-3%-$2,102+9+5
M
2017-04-07
MBVXMabvax Therapeutics Holdings, Inc.Hansen John DavidPres, CEOS - Sale$2.00-1,47671,689-2%-$2,955+9+5
2017-04-07
NKTRNektar TherapeuticsLingnau LutzDirS - Sale$20.05-7,00023,450-23%-$140,350-20
2017-04-10
MSLPMusclepharm CorpAmerop Holdings, Inc.10%P - Purchase$2.16+19,3002,136,781+1%+$41,600
2017-04-11
PTLAPortola Pharmaceuticals IncLis WilliamCEOS - Sale$36.06-6,7504,730-59%-$243,405+1+4
2017-04-10
PTLAPortola Pharmaceuticals IncFu TaoEVP, CBOS - Sale$36.97-1,0970-100%-$40,556+1+4
AM
2017-04-05
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.09+30,00020,088,8490%+$2,554
2017-04-10
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$7.60+33,000184,133,4560%+$250,842-1-6
AM
2017-04-06
NBRVNabriva Therapeutics AGHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$10.96-90,5942,669,286-3%-$992,542+7+3
M
2017-04-06
NBRVNabriva Therapeutics AGHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$10.96-90,594185,394-33%-$992,542+7+6
2017-04-07
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.24+5,0003,722,2570%+$1,200

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top